Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Proteome Sciences Logo
Proteome Sciences Growth Score
94
CB Rank
129869
Heat Score
82
Proteome Sciences is a protein biomarker company specializing in proteomics and peptidomics services and applications.
Founded
obfuscation
PublicPost-IPO Equity London, England, United Kingdom11-50 www.proteomics.com/
Biotechnology
Pharmaceutical
Overview

Proteome Sciences
Total Funding
obfuscation
Growth Score
94
Heat Score
82

Total Funding
obfuscation
obfuscation
Post-IPO Equity raised
obfuscation
Growth Score94
6 pts
in past quarter
Heat Score 82
16 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Proteome Sciences

CB Rank
129869
Proteome Sciences is a protein biomarker company specializing in proteomics and peptidomics services and applications.
Founded
obfuscation
PublicPost-IPO Equity London, England, United Kingdom11-50 www.proteomics.com/
Biotechnology
Pharmaceutical

Funding Rounds

Post-IPO Equity
OBF
in
obfuscation

Key People

Details

Operating Status Active
Stock Symbol  LSE:PRM
Company Type For Profit
About the Company

Proteome Sciences is a London (UK) and Frankfurt (Germany) based SME with expertise in proteomics and biomarker research. We have discovered and patented a large number of novel protein biomarkers for diagnosis, prognosis and treatment of key human diseases including neurodegenerative disorders, cancer, stroke etc. and provide protein biomarker

services to pharmaceutical and diagnostics companies.

Phone Number  +44 (0)20 7043 2116
Predictions & Insights

Growth Insight

See this Growth Insight
Proteome Sciences is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Products & Services

TMT Isobaric Mass Tags
Isobaric tagging reagents (TMT 11-plex, TMTpro 18-plex, TMTpro 35-plex) used for multiplexed protein quantification in mass spectrometry.
Contract Research Organization (CRO) Proteomic Services
Outsourced mass spectrometry-based proteomic analysis services including protein discovery, targeted assays, and biomarker quantification for various sample types.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity
obfuscation
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
2
obfuscation
— Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Photo of Richard Dennis
Richard Dennis
—
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
—
Photo of Richard Dennis
Richard Dennis
—
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
—
Photo of Richard Dennis
Richard Dennis
—
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
—
Photo of Richard Dennis
Richard Dennis
—
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
—
Photo of Richard Dennis
Richard Dennis
—
Post-IPO Equity - Proteome Sciences Logo
Post-IPO Equity - Proteome Sciences
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 1 Board Members and Advisors 1 Contacts 13

Employee Profiles

Board Members and Advisors

News

News and Press

News•Jun 22, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jun 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Feb 1, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jan 26, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

1,768
-22.22%
 in past month

IT Spend

$426.9KThis year, Proteome Sciences is projected to spend $426.9K on IT, according to Aberdeen.

Actively Used Products

6Proteome Sciences uses 6 technology products and services including HTML5, jQuery, and  Google Maps API, according to G2 Stack.

Active Website Tech Count

15Proteome Sciences is actively using 15 technologies for its website, according to BuiltWith. These include Viewport Meta, IPhone / Mobile Compatible, and  HSTS.

Total IP

1Proteome Sciences has 1 registered patent in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Proteome Sciences's headquarters? Proteome Sciences is located in London, England, United Kingdom.Who invested in Proteome Sciences? Proteome Sciences has 2 investors including Richard Dennis and  Vulpes Investment Management Pte Ltd.When was the last funding round for Proteome Sciences? Proteome Sciences closed its last funding round on
obfuscation
from a Post-IPO Equity round.Who are Proteome Sciences's competitors? Alternatives and possible competitors to Proteome Sciences may include Broad Institute, Sapient, and  Quantum SI.How much funding has Proteome Sciences raised to date? Proteome Sciences has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(be4ac66 1)
|